Irene Rivero Calle (Irene Rivero-Calle, I Rivero-Calle)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Topics

Community Acquired Pneumonia

Infectious Diseases

Acinetobacter Baumannii

Top Venues

Human vaccines & immunotherapeutics

Antibiotics (Basel, Switzerland)

Infection and drug resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Esther Redondo, Irene Rivero Calle, Enrique Mascarós, Daniel Ocaña, Isabel Jimeno, Ángel Gil-de Miguel, José Luis Díaz-Maroto, Manuel Linares, María Ángeles Onieva-García, Fernando González-Romo, Jose Yuste, Federico M Torres
Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Esther Redondo, Irene Rivero Calle, Enrique Mascarós, Daniel Ocaña, Isabel Jimeno, Ángel Gil-de Miguel, José Luis Díaz-Maroto, Manuel Linares, María Ángeles Onieva-García, Fernando González-Romo, Jose Yuste, Federico M Torres
Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Alexander James Martin, Fabian Johannes Stanislaus van der Velden, Ulrich von Both, Maria N Tsolia, Werner Zenz, Manfred Sagmeister, Clementien Vermont, Gabriella de Vries, Laura Kolberg, Emma J Lim, Marko Pokorn, Dace Zavadska, Federico M Torres, Irene Rivero Calle, Nienke N Hagedoorn, Effua Usuf, Luregn J Schlapbach, Taco W Kuijpers, Andrew J Pollard, Shunmay Yeung, Colin G Fink, Marie Voice, Enitan D Carrol, Philipp Kwame Abayie Agyeman, Aakash Khanijau, Stephane C Paulus, Tisham De, Jethro Adam Herberg, Michael Levin, Michiel van der Flier, Ronald de Groot, Ruud Gerard Gerard Nijman, Marieke Emonts, null null
External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised children. Archives of disease in childhood (2023)
Laura Kolberg, Aakash Khanijau, Fabian Johannes Stanislaus van der Velden, Jethro Herberg, Tisham De, Rachel Galassini, Aubrey J Cunnington, Victoria J Wright, Priyen Shah, Myrsini Kaforou, Clare Wilson, Taco W Kuijpers, Federico M Torres, Irene Rivero Calle, Henriette A Moll, Clementien Vermont, Marko Pokorn, Mojca Kolnik, Andrew J Pollard, Philipp Kwame Abayie Agyeman, Luregn J Schlapbach, Maria N Tsolia, Shunmay Yeung, Dace Zavadska, Werner Zenz, Nina A Schweintzger, Michiel van der Flier, Ronald de Groot, Effua Usuf, Marie Voice, Leonides Calvo-Bado, François Mallet, Katy Fidler, Michael Levin, Enitan D Carrol, Marieke Emonts, Ulrich von Both, null null
Raising AWaRe-ness of antimicrobial stewardship challenges in pediatric emergency care: results from the PERFORM study assessing consistency and appropriateness of antibiotic prescribing across Europe. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Narmeen Mallah, Jacobo Pardo-Seco, Sonia Ares Gomez, Luis-Ricardo López-Pérez, Juan-Manuel González-Pérez, Benigno Rosón, María-Teresa Otero-Barrós, Carmen Durán-Parrondo, Victoria Nartallo-Penas, Susana Mirás-Carballal, Carmen Rodríguez-Tenreiro-Sánchez, Irene Rivero Calle, Alberto Gómez-Carballa, Antonio Salas, Federico M Torres
COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 34 (10) (2023)
Antonio Salas, Irene Rivero Calle, Federico M Torres
Chatting with ChatGPT to learn about safety of COVID-19 vaccines - A perspective. Human vaccines & immunotherapeutics 19 (2) (2023)
Antonio Salas, Irene Rivero Calle, Federico M Torres
Chatting with ChatGPT to learn about safety of COVID-19 vaccines - A perspective. Human vaccines & immunotherapeutics 19 (2) (2023)
Irene Rivero Calle, Peter Francis N Raguindin, Jacobo Pardo-Seco, Federico M Torres
Risk Analysis by Age on the Burden of Meningococcal Disease in Spain. Vaccines 10 (4) (2022)
Dorine M Borensztajn, Nienke N Hagedoorn, Irene Rivero Calle, Ian K Maconochie, Ulrich von Both, Enitan D Carrol, Juan Emmanuel Dewez, Marieke Emonts, Michiel van der Flier, Ronald de Groot, Jethro Herberg, Benno Kohlmaier, Emma Lim, Federico M Torres, Daan Nieboer, Ruud Gerard Gerard Nijman, Marko Pokorn, Franc Strle, Maria Tsolia, Clementien Vermont, Shunmay Yeung, Dace Zavadska, Werner Zenz, Michael Levin, Henriette A Moll, null null
Variation in hospital admission in febrile children evaluated at the Emergency Department (ED) in Europe: PERFORM, a multicentre prospective observational study. PloS one 16 (1) (2021)
Jose Gómez-Rial, Irene Rivero Calle, Antonio Salas, Federico M Torres
Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy. Infection and drug resistance 13 (2020)
Irene Rivero Calle, Jose Gómez-Rial, Louis Bont, Bradford D Gessner, Melvin Kohn, Ron Dagan, Daniel C Payne, Laia Bruni, Andrew J Pollard, Adolfo García-Sastre, Denise L Faustman, Albert Osterhaus, Robb Butler, Francisco Giménez Sánchez, Francisco Álvarez, Myrsini Kaforou, Xabier Bello, Federico M Torres
TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines. Human vaccines & immunotherapeutics 17 (3) (2020)
Irene Rivero Calle, Peter Francis N Raguindin, Jose Gómez-Rial, Carmen Rodriguez-Tenreiro, Federico M Torres
Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B. Infection and drug resistance 12 (2019)
Irene Rivero Calle, J Pardo Seco, Peter Francis N Raguindin, F Alvez, J Gómez-Rial, Antonio Salas, J Martinón Sanchez, Federico M Torres
Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain. Human vaccines & immunotherapeutics 16 (6) (2019)
Pablo Obando-Pacheco, Irene Rivero Calle, Peter Francis N Raguindin, Federico M Torres
DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age. Expert review of vaccines 18 (11) (2019)
Antonio Salas, Jacobo Pardo-Seco, Ruth Barral-Arca, Miriam Cebey-López, Alberto Gómez-Carballa, Irene Rivero Calle, Sara Pischedda, María-José Currás-Tuala, Jorge Amigo, José Gómez-Rial, Federico M Torres, null null
Whole Exome Sequencing Identifies New Host Genomic Susceptibility Factors in Empyema Caused by Streptococcus pneumoniae in Children: A Pilot Study. Genes 9 (5) (2018)